Kimberly McHale

Kimberly McHale has a diverse work experience in the field of nonclinical science and research. Kimberly is currently working at Dermavant Sciences as a Sr. Director of Nonclinical Science, a role they started in April 2022. Prior to this, they held roles as the Director of Nonclinical Science and Associate Director of Nonclinical Science at the same company.

Before joining Dermavant Sciences, Kimberly worked at Roivant Sciences as an Associate Director of Nonclinical Pharmacology and Senior Manager of Pharmacology. Kimberly also has experience at Novan Therapeutics where they served as a Senior Scientist in Research and Nonclinical Development. Here, they focused on evaluating the antibacterial efficacy of the company's nitric oxide-releasing technology and conducting whole-genome analysis of potential resistant organisms. Kimberly also held the role of a Molecular Microbiologist post-doc and performed various experiments related to microbiology.

Kimberly's early career included working as a Graduate Research Assistant at the University of North Carolina at Chapel Hill School of Medicine, where they conducted research on transcription factors and receptor-ligand interactions in Pseudomonas aeruginosa. Additionally, they worked as a Teaching Assistant at Micro 255, UNC, and as a Student Researcher at the University of Pittsburgh.

Overall, Kimberly McHale has a strong background in nonclinical science, with experience in multiple research projects and leadership positions.

Kimberly McHale obtained their Bachelor of Science in Medical Biology from the University of New England between 2004 and 2007. Kimberly then pursued Medicine at the University of North Carolina at Chapel Hill School of Medicine from 2007 to 2012.